Phibro Animal Health Corp. - Ordinary Shares - Class A
PAHC
Get informed when a big investor buys or sells
+ FollowMarket Cap$1.55B
Close$
$-4.40
111.5% downside
Current Fair Value
111.5% downsideOvervalued by 111.5% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $1.55 Billion |
|---|---|
| Enterprise Value | $2.28 Billion |
| Dividend Yield | $0.48 (1.25%) |
| Earnings per Share | $2.46 |
| Beta | 0.46 |
| Outstanding Shares | 40,600,000 |
Return
| Return on Equity | 25.87% |
|---|---|
| Return on Assets | 6.64% |
| Return on Invested Capital | 15.93% |
Valuation & Multiples
| P/E Ratio | 15.55 |
|---|---|
| PEG | 59.7 |
| Price to Sales | 1.03 |
| Price to Book Ratio | 4.25 |
| Enterprise Value to Revenue | 1.5 |
| Enterprise Value to EBIT | 12.07 |
| Enterprise Value to Net Income | 22 |
| Total Debt to Enterprise | 0.35 |
| Debt to Equity | 2.05 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
September 2, 2026
EPS Estimate
$0.72
Average shareholder expectationRevenue Estimate
$386.49 M
Average shareholder expectationNext Earnings Call
Expected Date
November 4, 2026
EPS Estimate
$0.77
Average shareholder expectationRevenue Estimate
$379.38 M
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 3.7895▲ 24.63% |
|---|---|
| Total Calls | 15,200▼ 6.17% |
| Total Puts | 57,600▲ 0.35% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 54.60%▲ 4.37% |
|---|---|
| Total Invested | $696.22M▼ 38.06% |
| Investors Holding | 214▼ 48.00% |
ESG Score
No data
About Phibro Animal Health Corp.
CEO: Jack Bendheim